338 related articles for article (PubMed ID: 23915911)
1. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
[TBL] [Abstract][Full Text] [Related]
2. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Significance of S100A10 Expression in Lung Adenocarcinomas.
Katono K; Sato Y; Jiang SX; Kobayashi M; Saito K; Nagashio R; Ryuge S; Satoh Y; Saegusa M; Masuda N
Asian Pac J Cancer Prev; 2016; 17(1):289-94. PubMed ID: 26838226
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
5. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
6. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
7. Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.
Lee JG; Kim S; Shim HS
Lung Cancer; 2012 Jul; 77(1):156-61. PubMed ID: 22418245
[TBL] [Abstract][Full Text] [Related]
8. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
[TBL] [Abstract][Full Text] [Related]
9. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II
Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Hiyoshi Y; Sato Y; Ichinoe M; Nagashio R; Hagiuda D; Kobayashi M; Kusuhara S; Igawa S; Shiomi K; Goshima N; Murakumo Y; Saegusa M; Satoh Y; Masuda N; Naoki K
Thorac Cancer; 2019 Nov; 10(11):2142-2151. PubMed ID: 31583841
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
15. LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma.
Ehara T; Uehara T; Nakajima T; Kinugawa Y; Kobayashi S; Iwaya M; Ota H; Soejima Y
BMC Cancer; 2021 Mar; 21(1):228. PubMed ID: 33676447
[TBL] [Abstract][Full Text] [Related]
16. Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.
Matsumoto T; Nagashio R; Ryuge S; Igawa S; Kobayashi M; Fukuda E; Goshima N; Ichinoe M; Jiang SX; Satoh Y; Masuda N; Murakumo Y; Saegusa M; Sato Y
Pathol Int; 2018 Apr; 68(4):232-240. PubMed ID: 29431238
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic significances of MUC5B and TTF-1 expressions in resected non-small cell lung cancer.
Nagashio R; Ueda J; Ryuge S; Nakashima H; Jiang SX; Kobayashi M; Yanagita K; Katono K; Satoh Y; Masuda N; Murakumo Y; Hachimura K; Sato Y
Sci Rep; 2015 Mar; 5():8649. PubMed ID: 25733373
[TBL] [Abstract][Full Text] [Related]
18. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K
Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999
[TBL] [Abstract][Full Text] [Related]
19. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Suga T; Ota H; Tanaka E
Ann Diagn Pathol; 2019 Jun; 40():161-165. PubMed ID: 31100646
[TBL] [Abstract][Full Text] [Related]
20. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
